Navigation Links
LS9, Inc., U.C Berkeley, and JBEI Make Major Breakthrough in Cellulosic Fuels Production
Date:1/27/2010

Researchers Develop Microbes that Produce Fuels Directly from Cellulosic Biomass

South San Francisco, CA (PRWEB) January 27, 2010 -- LS9, Inc, the Renewable Petroleum Company™, today announced a major breakthrough in the ability to make cellulosic-derived advanced biofuels. A collaborative team of researchers from LS9, Inc, the University of California at Berkeley, and the U.S. Department of Energy’s Joint BioEnergy Institute (JBEI) have developed a microbe that can produce an advanced biofuel directly from cellulosic biomass in a one-step process.

Using the power of synthetic biology, the team of researchers engineered a microbe that consolidates advanced biofuels production and cellulosic bioprocessing for the first time. This breakthrough enables the production of advanced hydrocarbon fuels and chemicals in a single fermentation process that does not require additional chemical transformations.

“This breakthrough is a significant step toward the development of scalable, low-cost drop in compatible cellulosic fuels and chemicals,” said Dr. Stephen del Cardayre, Vice President, Research and Development, LS9 Inc. “Combining LS9’s single-step advanced fuel and chemical fermentation processes with cellulosic bioprocessing will enable the production of petroleum replacement products at lower costs and with significantly lower carbon emissions than current petroleum-based fuels and chemicals.”

The team of scientific collaborators that included LS9 scientists Zhihao Hu, Andreas, Schirmer, Amy McClure, and Stephen del Cardayre, and the U.C. Berkeley and JBEI team of Eric Stein, Yisheng Kang, Gregory Bokinsky and Jay Keasling, have published the results of this research in the January 28, 2010 edition of the journal Nature. The p
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioSpec Global Solutions Inc., contracts with RMF Design & Manufacturing Inc., for production of the TOGs 3000 and 9000 units for U.S. market
2. Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
3. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
4. BioStorage Technologies, Inc., Welcomes Catherine Michael as Global Head of Sample Management Operations
5. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
6. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
7. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
8. Buehler Motor, Inc., Significantly Expands Customer and Partner Support in North America
9. Providence-Based NABsys, Inc., Announces $4 Million Equity Financing
10. CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2
11. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces the ... office space for Shire a leading biopharmaceutical company, at Two ... | RBJ,s Robert Richards , president, and Brian ... for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
Breaking Biology Technology:Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... Be Free of the Side Effects Associated with ... CeNeRx BioPharma, Inc., a clinical stage company ... the central nervous system (CNS), today announced issuance ... compounds that selectively target peripheral cannabinoid receptors. ...
... , ... Rochester, New York (PRWEB) April 1, 2009 ... were used successfully in a clinical study to model the effect ... ,The repolarization biomarkers, captured on a continuous electrocardiogram, played a key ...
... March 31 Alseres Pharmaceuticals, Inc. (Nasdaq: ... of the Company,s independent registered public accounting firm ... explanatory paragraph regarding the Company,s ability to continue ... NASDAQ-traded companies to publicly announce if their Annual ...
Cached Biology Technology:CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors 2CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors 3iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study for Top Pharmaceutical Company 2Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K 2Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K 3
(Date:1/22/2015)...  Today, FreeWavz ( www.FreeWavz.com ), the developer of ... Fundable, https://www.fundable.com/freewavz . FreeWavz will be expanding ... meet customer demand. Logo - ... Invented by Dr. Eric ...
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... of the worlds leading marine biologists will gather in Auckland ... life from the poles to the tropics. This major meeting ... Marine Life, is being jointly hosted by the National Institute ... Auckland. The Census of Marine Life is ...
... Reserve Universitys School of Medicine have published in ... a natural product derived from the Amazon rainforest. ... of applications in various joint, skin and gastrointestinal ... publication revealed that Progrado, an extract from a ...
... 24, 2007 The vast majority of patients ... MitraClip device did not need mitral valve surgery ... from significantly improved function of the left ventricle ... presented this week at the Cardiovascular Research Foundations ...
Cached Biology News:Natural product discovery by Cleveland medical researchers blocks tissue destruction 2New data shows benefits of MitraClip for patients with mitral regurgitation 2New data shows benefits of MitraClip for patients with mitral regurgitation 3
Proliferin (C-14)...
... Rabbit polyclonal to Dideoxycytidine Dideoxycytidine is a ... effective in inhibiting retroviral activity. Immunogen: ... Specificity: The specificity of the ... of the moles of ddC to moles of ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
...
Biology Products: